Concorde Asset Management LLC acquired a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) during the first quarter, according to its most recent filing with the SEC. The fund acquired 1,098 shares of the company’s stock, valued at approximately $227,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. William Blair Investment Management LLC purchased a new stake in Inspire Medical Systems during the 4th quarter valued at about $99,327,000. Norges Bank purchased a new stake in Inspire Medical Systems in the 4th quarter worth approximately $48,958,000. Credit Suisse AG lifted its holdings in Inspire Medical Systems by 49.0% in the 4th quarter. Credit Suisse AG now owns 625,573 shares of the company’s stock worth $117,664,000 after buying an additional 205,692 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Inspire Medical Systems by 5,474.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 170,923 shares of the company’s stock worth $32,149,000 after acquiring an additional 167,857 shares in the last quarter. Finally, BlackRock Inc. boosted its stake in Inspire Medical Systems by 4.8% during the 4th quarter. BlackRock Inc. now owns 1,993,714 shares of the company’s stock valued at $374,998,000 after purchasing an additional 91,563 shares during the last quarter. Institutional investors and hedge funds own 96.30% of the company’s stock.
A number of equities analysts have recently issued reports on the company. Piper Sandler raised their price target on Inspire Medical Systems from $210.00 to $252.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 2nd. Zacks Investment Research downgraded Inspire Medical Systems from a “hold” rating to a “sell” rating in a research report on Wednesday, April 28th. SVB Leerink lifted their target price on Inspire Medical Systems from $225.00 to $275.00 and gave the company an “outperform” rating in a research report on Tuesday, March 2nd. Robert W. Baird reiterated a “buy” rating on shares of Inspire Medical Systems in a research report on Sunday, April 25th. Finally, Lake Street Capital lifted their target price on Inspire Medical Systems from $215.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, February 24th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. Inspire Medical Systems has a consensus rating of “Buy” and a consensus price target of $171.50.
Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Tuesday, February 23rd. The company reported ($0.28) EPS for the quarter, topping analysts’ consensus estimates of ($0.45) by $0.17. The company had revenue of $46.01 million during the quarter, compared to the consensus estimate of $39.20 million. Inspire Medical Systems had a negative net margin of 61.07% and a negative return on equity of 32.23%. Inspire Medical Systems’s revenue for the quarter was up 71.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.38) earnings per share. On average, sell-side analysts expect that Inspire Medical Systems, Inc. will post -2.37 EPS for the current year.
Inspire Medical Systems Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Further Reading: Shanghai Stock Exchange Composite Index
Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP).
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.